Stryker (SYK) is now covered by Leerink Partners. They set an "outperform" rating and a $410.00 price target on the stock.
Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio
Stryker (SYK) had its price target lowered by The Goldman Sachs Group, Inc. from $403.00 to $357.00. They now have a "neutral" rating on the stock.
Orthopedic Power Tools Market to Reach US$ 2.6 Billion by 2033 Expands Amid Surgical Innovation and Rising Procedure Volumes [Yahoo! Finance]
Stryker (SYK) had its price target lowered by Citigroup Inc. from $420.00 to $385.00. They now have a "buy" rating on the stock.